Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13728-13733
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13728
Table 1 Immunohistochemical studies in gastric cancer patients with histological node negatively diagnosed by hematoxylin-eosin staining n (%)
Ref.YearMarkerDepth of tumor invasionNo. of patientsNo. of micrometastatic patients5-yr survivalP value
Maehara et al[4]1996CAM5.2T1348 (23.5)N/AN/A
Cai et al[1]2000CAM5.2T1b6917 (24.6)82% vs 100%< 0.010
Harrison et al[42]2000CAM5.2T1-T4259 (36)35% vs 66%0.048
Nakajo et al[41]2001AE1/AE3T1-T36710 (14.9)N/AN/A
Fukagawa et al[40]2001AE1/AE3T2-T310738 (35.5)94% vs 89%0.86
Morgagni et al[39]2001MNF116T113924 (17.3)87% vs 88%0.6564
Choi et al[38]200235βH11Tib8828 (31.8)92.9% vs 95%0.6836
Yasuda et al[29]2002CAM5.2T2-T4a6420 (31.3)66% vs 95%< 0.010
Morgagni et al[37]2003MNF116T130030 (10)94% vs 89%0.7794
Miyake et al[36]2006AE1/AE3T112027 (22.5)N/AN/A
Yonemura et al[35]2007AE1/AE3T1-T430837 (12)N/AN/A
Kim et al[30]2008AE1/AE3T1-T4a18431 (16.8)58.5% vs 91.8%< 0.001
Ishii et al[34]2008O.N.352T1b-T2354 (11)N/AN/A
Kim et al[33]2009AE1/AE3T1909 (10)N/AN/A
Cao et al[32]2011AE1/AE3T116034 (21.3)55.9% vs 92.9%< 0.001
Wang et al[31]2011AE1/AE3T1-T319154 (28.3)27.8% vs 87.1%< 0.001
Table 2 Reverse transcription-polymerase chain reaction studies in gastric cancer patients with histological node negativity diagnosed by hematoxylin-eosin staining n (%)
Ref.YearMarkersDepth of tumor invasionNo. of patientsNo. of total LNsNo. of micrometastatic patientsOutcomes
Okada et al[16]2001CEA, CK20, MAGE3T1-T4a2433510 (41.7)N/A
Matsumoto et al[17]2002CEAT1-T45031214 (28)N/A
Arigami et al[18]2005CEAT1-T380186225 (31.3)N/A
Sonoda et al[24]2006MUC2, TFF1T13331011 (33)N/A